SetPoint Medical Secures $140 Million in Private Funding

Summary:

1. SetPoint Medical, a company in Valencia, CA, secured $140M in private financing for therapies targeting chronic autoimmune diseases.
2. The funding will support the U.S. commercialization of the FDA-approved SetPoint System for rheumatoid arthritis and advance research in other autoimmune conditions.
3. SetPoint Medical utilizes neurostimulation to activate anti-inflammatory pathways in the vagus nerve, aiming to reduce inflammation and restore immunologic balance.

   Article:
   SetPoint Medical, a California-based company focusing on developing treatments for chronic autoimmune diseases, recently announced a significant milestone in its journey. With a successful private financing round raising $140M, the company is poised to make a significant impact in the healthcare industry. This funding includes $25M from the second tranche of its Series C round and $115M from its Series D round, which was co-led by Elevage Medical Technologies and Ally Bridge Group.

   The primary goal of this financing is to support the U.S. commercialization of SetPoint Medical’s groundbreaking SetPoint System. This innovative neuroimmune modulation therapy targets moderate-to-severe rheumatoid arthritis (RA) and has already received approval from the FDA. In addition to advancing the commercialization of this therapy, the company plans to use the funds to further its research and development efforts in other autoimmune conditions.

   SetPoint Medical sets itself apart with its proprietary integrated neurostimulation platform, which harnesses the power of the vagus nerve to activate innate anti-inflammatory pathways. By doing so, the company aims to reduce inflammation and restore immunologic balance in individuals living with chronic autoimmune diseases. This approach holds promise for improving care and quality of life for patients facing these challenging conditions.

   In conclusion, SetPoint Medical’s recent financing success marks a significant step forward in the company’s mission to revolutionize treatment options for individuals with chronic autoimmune diseases. With a focus on innovation and research, SetPoint Medical is well-positioned to make a meaningful impact in the healthcare landscape and bring hope to those in need of effective therapies.